These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15404484)

  • 21. Another milestone in childhood spinal muscular atrophy.
    Wokke JH
    Lancet Neurol; 2017 Jul; 16(7):491-492. PubMed ID: 28460890
    [No Abstract]   [Full Text] [Related]  

  • 22. Spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K
    J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population data on acute infantile and chronic childhood spinal muscular atrophy in Warsaw.
    Spiegler AW; Hausmanowa-Pertrusewicz I; Borkowska J; Kłopocka A
    Hum Genet; 1990 Jul; 85(2):211-4. PubMed ID: 2370051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Infantile spinal amyotrophy with myotonia. Electromyographic study].
    Renault F
    Neurophysiol Clin; 1989 May; 19(2):155-61. PubMed ID: 2725454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy for Spinal Muscular Atrophy.
    Mendell JR
    N Engl J Med; 2018 Feb; 378(5):487. PubMed ID: 29394473
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapy for Spinal Muscular Atrophy.
    Whittaker HT; Michell-Robinson MA
    N Engl J Med; 2018 Feb; 378(5):487. PubMed ID: 29394306
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapy for Spinal Muscular Atrophy.
    Finkel RS; Farwell W
    N Engl J Med; 2018 Feb; 378(5):487-488. PubMed ID: 29385371
    [No Abstract]   [Full Text] [Related]  

  • 28. [Usefulness of ECG in the early diagnosis of infantile spinal muscular dystrophy].
    Carboni P; Porro G
    Minerva Pediatr; 1988 Jun; 40(6):321-5. PubMed ID: 3185431
    [No Abstract]   [Full Text] [Related]  

  • 29. [Forty cases of Werdnig-Hoffmann disease with eleven anatomical examinations].
    THIEFFRY S; ARTHUIS M; BARGETON E
    Rev Neurol (Paris); 1955 Oct; 93(4):621-44. PubMed ID: 13298385
    [No Abstract]   [Full Text] [Related]  

  • 30. Statistical considerations in the study of spinal muscular atrophy. Dallas-Cincinnati-Newington Spinal Muscular Atrophy (DCN-SMA) Study Group.
    Buncher CR; Samaha F; Iannaccone ST; Russman BS; Cook JD; White M; McLaughlin C
    Muscle Nerve; 1990; 13 Suppl():S45-8. PubMed ID: 2233886
    [No Abstract]   [Full Text] [Related]  

  • 31. Stakeholder collaboration for spinal muscular atrophy therapy development.
    Aartsma-Rus A; Balabanov P; Binetti L; Haas M; Haberkamp M; Mitchell J; Rosa MM; Muntoni F; Finkel R; Mercuri E
    Lancet Neurol; 2017 Apr; 16(4):264. PubMed ID: 28327335
    [No Abstract]   [Full Text] [Related]  

  • 32. New Frontiers in the Treatment of Spinal Muscular Atrophy.
    Power CL; O'Rourke DJ
    Ir Med J; 2018 Mar; 111(3):705. PubMed ID: 30376223
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic therapies for spinal muscular atrophy type 1.
    Aartsma-Rus A
    Lancet Neurol; 2018 Feb; 17(2):111-112. PubMed ID: 29229374
    [No Abstract]   [Full Text] [Related]  

  • 34. [Spinal muscular atrophy in young infants].
    Smit LM; Hageman EG
    Tijdschr Kindergeneeskd; 1989 Jun; 57(3):102-6. PubMed ID: 2799798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Difficulty in surrogate decision making in spinal muscular atrophy type 1].
    Laxe S
    An Pediatr (Barc); 2016 Sep; 85(3):165. PubMed ID: 27198884
    [No Abstract]   [Full Text] [Related]  

  • 36. Spinal and bulbar muscular atrophy without tongue atrophy.
    Sugawara M; Kato K; Watanabe S; Toyoshima I
    Eur Neurol; 2001; 45(3):185-6. PubMed ID: 11306865
    [No Abstract]   [Full Text] [Related]  

  • 37. Lumbosacral ventral spinal nerve root atrophy identified on MRI in a case of spinal muscular atrophy type II.
    Smith G; Bell SK; Sladky JT; Kang PB; Albayram MS
    Clin Imaging; 2019; 53():134-137. PubMed ID: 30340076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum cholinesterase activity in infantile and juvenile spinal muscular atrophy.
    Niebroj-Dobosz I; Hausmanowa-Petrusewicz I
    Acta Neurol Scand; 1989 Sep; 80(3):208-14. PubMed ID: 2801018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and future treatments of spinal muscular atrophy.
    Smith M
    Dev Med Child Neurol; 2020 Mar; 62(3):267. PubMed ID: 31879942
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism.
    Fidziańska A; Goebel HH; Warlo I
    Brain; 1990 Apr; 113 ( Pt 2)():433-45. PubMed ID: 2328412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.